Interview with ODI Pharma’s Chairman of the Board Volker Wiederrich
Kommentar
2024-05-17
Comment on Björn Borgs Q1 Report for 2024
Analys
Arctic Blue Beverages Q1-24
2024-05-16
Comment on PEG’s Q1 Report for 2024
Kommentar på First Ventures Q1-rapport
TCECUR Q1-24